Previous studies have also found that in gemcitabine-resistant pancreatic cancer cell lines, pyrimidine synthesis increases, leading to gemcitabine resistance through the HIF-1α-induced aerobic glycolysis pathway [36]. This evidence concerns the gene HIF1A and pancreatic neoplasm.